switching from compounded semaglutide to zepbound a a brand-name GLP-1? Here's how to do it in 5 steps How to switch from Zepbound

Current expectations point to FDA review and potential approval in the 2027 to 2028 range

Excess adipose tissue, especially visceral fat, produces inflammatory compounds and can increase aromatase activity, converting testosterone to estrogen

The FDA has expressed several concerns that many of these compounded products: are marketed like FDA-approved drugs

GLP-1 medications can help reduce your appetite and support weight loss, with studies showing they can help people lose an average of 15 to 20% of their body weight

Our goal is to integrate these medications into a personalized health and wellness plan tailored to your needs, ensuring a safe and effective approach to achieving long-term weight loss and overall well-being